Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Trial of High-Flow Nasal Cannula vs. Conventional Oxygen Therapy in Patients With SARS-CoV-2-Related Acute Respiratory Failure: the HiFlo-COVID Trial.

NCT04609462 is registered in ClinicalTrials.gov with Fundacion Clinica Valle del Lili as lead sponsor.

NCT NCT04609462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04609462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Trial of High-Flow Nasal Cannula vs. Conventional Oxygen Therapy in Patients With SARS-CoV-2-Related Acute Respiratory Failure: the HiFlo-COVID Trial.
Lead sponsor
Fundacion Clinica Valle del Lili
Phase
Not applicable
Overall status
Completed
Start date
August 11, 2020
Completion date
February 10, 2021
Enrollment
199 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute hypoxemic respiratory failure, covid19